Diabetes Clinical Trials in North Carolina

Showing 121-140 of 292 trials

A Study of LY3209590 in Participants With Type 2 Diabetes

NCT03367377

This study will evaluate the safety and tolerability of LY3209590 when given by injection under the skin to participants with type 2 diabetes. It will also investigate how the body processes the study drug and the effect of the study drug on blood sugar levels. Information about any side effects will be documented. This study will last approximately 17 weeks, not including screening. Screening is required within 4 weeks prior to the start of the study.

Diabetes Mellitus, Type 2

Eli Lilly and Company70 participantsStarted Jan 2018

South Miami, Florida, United States • High Point, North Carolina, United States • Toronto, Ontario, Canada

COMPLETEDPHASE228 miles

Safety and Efficacy of Relamorelin Administered to Participants With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis

NCT02357420

The purpose of this study is to evaluate the effects of multiple dose regimens of relamorelin on vomiting episodes, gastric emptying and gastroparesis symptoms in participants with Type 1 and Type 2 diabetes mellitus and gastroparesis. Study drug (relamorelin and placebo) will be administered subcutaneously in a blinded fashion.

Diabetes MellitusDiabetes Mellitus ComplicationsGastroparesis

Allergan393 participantsStarted Jan 2015

Dothan, Alabama, United States • Huntsville, Alabama, United States • Tucson, Arizona, United States +95 more locations

A Study of LY3209590 in Participants With Type 2 Diabetes

Safety and Efficacy of Relamorelin Administered to Participants With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis

Diabetes Trials in Other Cities

Efficacy and Safety of Semaglutide Once-weekly Versus Exenatide ER 2.0 mg Once-weekly as add-on to 1-2 Oral Antidiabetic Drugs (OADs) in Subjects With Type 2 Diabetes

A 6-month Clinical Study to Evaluate the Effect of a Digital Disease Management Tool in Patients With T2DM

Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus

Safety, Tolerability and Efficacy of ISIS-GCGRRx in Patients With Type 2 Diabetes

A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c

Latinos Combating Diabetes

Efficacy and Safety of Toujeo® Versus Tresiba® in Insulin-Naive Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Oral Antihyperglycemic Drug(s) ± GLP-1 Receptor Agonist

Dose-finding of Semaglutide Administered Subcutaneously Once Daily Versus Placebo and Liraglutide in Subjects With Type 2 Diabetes

Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes

Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data

Hybrid Closed Loop Pivotal Trial in Type 1 Diabetes

Evaluation of the Accuracy of an Implanted Glucose Sensor

A Trial Investigating the Efficacy and Safety of Insulin Degludec in Children and Adolescents With Type 1 Diabetes Mellitus

Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes

Physical and Cognitive Function - Look AHEAD Ancillary Study

A Study to Evaluate the Safety of THR-149 in Subjects With Diabetic Macular Edema (DME)

REducing With MetfOrmin Vascular Adverse Lesions in Type 1 Diabetes (REMOVAL)

Pharmacist-led Group Medical Visits to Help With Diabetes Management

Other Conditions in North Carolina